CAVA: Capital Research Reports 5.3% Stake
CAVA Group, Inc. Schedule 13G/A reports that Capital Research Global Investors beneficially owns 6,137,481 shares of CAVA common stock, representing 5.3% of the 116,377,765 shares believed outstanding as disclosed in the filing dated 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CAVA Group, Inc. Schedule 13G/A reports that Capital Research Global Investors beneficially owns 6,137,481 shares of CAVA common stock, representing 5.3% of the 116,377,765 shares believed outstanding as disclosed in the filing dated 03/31/2026. The filing shows CRGI has sole voting power over 6,124,278 shares and sole dispositive power over 6,137,481 shares.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficially owned financial
sole dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Capital Research Global Investors hold in CAVA (CAVA)?
Does the Schedule 13G/A show voting or dispositive power for CRGI in CAVA?
Who filed the amendment for this CAVA Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.